| CACELGO BRISTOL-MYERS SQUIBB COMPANY
(A DELAWARE CORPORATION)
1408865 28 Aug 2008 | on 21 Sep 2011 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases, stroke, cancer, and auto-immune diseases namely rheumatoid arthritis, multiple sclerosis, lupus, psoriatic arthritis, psoriasis, ankolysing spondylitis, Crohn's disease and ulcerative colitis; Pharmaceutical preparations for treatment of the respiratory system; antibiotics, anti-inflammatories, and anti-infectives; anti-psychotics, central nervous system stimulants, central nervous system depressants. | | | CACELGO BRISTOL-MYERS SQUIBB COMPANY
(A DELAWARE CORPORATION)
1155693 08 Oct 2002 | on 29 Oct 2008 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases, stroke, cancer, and auto-immune diseases namely rheumatoid arthritis, multiple sclerosis, lupus, psoriatic arthritis, psoriasis, ankolysing spondylitis, Crohn's disease and ulcerative colitis; Pharmaceutical preparations for treatment of the respiratory system; antibiotics, anti-inflammatories, and anti-infectives; anti-psychotics, central nervous system stimulants, central nervous system depressants. | | 
